Send to

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 2003 Mar 24;88(6):803-7.

Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy.

Author information

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare 'L. Califano', Istituto di Endocrinologia ed Oncologia Sperimentale 'G. Salvatore' del Consiglio Nazionale delle Ricerche, Universit√† Federico II, via S. Pansini 5, Napoli 80131, Italy.


In this review, we discuss the available experimental evidences supporting the chemopreventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and the biological basis for their possible role as anticancer agents. Although the comprehension of the mechanisms underlying the effects of these drugs on colon cancer cells is incomplete, research efforts in identifying the biochemical pathway by which NSAIDs exert their chemopreventive effect have provided a rationale for the potential use of NSAIDs alone or in combination with conventional and experimental anticancer agents in the treatment of colorectal cancer. In this paper, we review three main issues: (i) the role of COX-2 in colon cancer; (ii) the common death pathways between NSAIDs and anticancer drugs; and (iii) the biological basis for the combination therapy with COX-2 selective inhibitors and new selective inhibitors of growth factor signal transduction pathways.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center